Skip to content
Modern Fortune Connect

Users Coming Off Weight-Loss Jabs Put On Weight Four Times Faster Compared to People Using Diet and Exercise

Image of medical syringe and scale
Weight management often requires long-term strategies.

A recent study suggests that people who stop using new weight-loss injections like Mounjaro or Wegovy may regain shed pounds much more quickly than those who end traditional lifestyle regimens.

Published data in a prominent medical journal demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.

"Users using such drugs need to be aware of the potential of fast weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.

That rate of regain suggests a return to pre-treatment mass within about 18 months.

Comparing Therapies

The study, which looked at 37 of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.

The team emphasize that people who shed pounds through dieting usually have a more gradual weight regain—around 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Nutrition scientists propose the mode of action of the injections accounts for the heightened weight return.

GLP-1 drugs imitate a body's own chemical called GLP-1, which controls appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication leads to appetite is unsuppressed, making excessive eating much more probable."

A Chronic Issue?

Medical guidelines suggest the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Professionals contend that, considering the significant potential of relapse, the treatment should be considered ongoing.

This opinion is supported by drug manufacturers, who note that the results "highlight the long-term nature of excess weight," similar to managing diseases like hypertension.

User Testimonies

Individuals who have come off the jabs describe a intense return of appetite.

"I experienced a switch that goes on and you become starving," described an individual.

This challenge is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during therapy.

Growing Interest

Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.

  • Adoption is greater among females than men.
  • The 40s and 50s demographic shows the highest usage rates.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a permanent fix and long-term success likely depends on ongoing lifestyle support.

AJ
Written by

Adrian Jennings

Elena M. Caldwell is a financial analyst and writer with over a decade of experience helping individuals achieve financial independence through smart strategies.

Modern Fortune Connect

Type to search articles.